A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
- Procalcitonin-guided algorithm safely reduces duration of antibiotic therapy on December 10, 2018 at 11:09 am
“We did a prospective evaluation of procalcitonin, comparing it to a preintervention group,” Jennifer Townsend, MD, director of antimicrobial stewardship and medical director of outpatient parenteral ... […]
- Antimicrobial Use and Antimicrobial Resistance FAQ on December 9, 2018 at 4:37 am
... of antimicrobial resistance in organisms that infect animals because it may compromise the effectiveness of antimicrobial therapy for animal diseases and make them harder to treat. Antimicrobials ... […]
- One Health series: The politics of antimicrobial resistance on December 8, 2018 at 6:27 am
“We need to develop rapid diagnostics, antibiotic alternatives, particularly phage therapy. We need state-of-the-art sanitation ... are embracing a One Health approach to addressing antimicrobial resi... […]
- Aridis to Start Phase 1/2a Trial for Inhalable Antibacterial Therapy AR-501 in CF Patients on December 7, 2018 at 5:58 am
These are expected to support and expedite the therapy’s development and regulatory review ... In addition, it is a broad-spectrum antimicrobial agent “with a low propensity for developing drug resist... […]
- 5 key strategies to mitigate the effect of antimicrobial resistance on December 5, 2018 at 3:22 pm
However, if institutions place greater emphasis on strategies to fight this resistance, such as ensuring appropriate antimicrobial therapy and developing robust antibiotic stewardship initiatives, hea... […]
- GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2 on December 5, 2018 at 10:03 am
Delayed antimicrobial therapy significantly increases mortality in high-risk infections with a particularly strong association with septic shock. Therefore, antimicrobial agents are often injudiciousl... […]
- Tacking antimicrobial resistance was key topic at mastitis conference on November 26, 2018 at 10:21 pm
Whole herd antibiotic dry cow therapy (DCT) has been one of the mainstays of mastitis ... the use of antibiotics will continue to increase due to mounting concerns over antimicrobial resistance and th... […]
- R&M expands antimicrobial cabling solution range for healthcare data networks in the Middle East on November 16, 2018 at 4:47 am
Since its launch in 2016, hospitals across the globe have begun to utilize R&MhealthLine components in rooms for patients, in diagnosis and therapy, as well as in operating theatres. The antimicrobial ... […]
- Updated Guidelines Advise on Outpatient Parenteral Antimicrobial Therapy on November 14, 2018 at 8:58 am
An infectious diseases (ID) specialist should be consulted before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital, suggest updated guidelines released by the I... […]
via Bing News